Microtek Drape Revenue Will Benefit From Revamped Sales Model – CEO
This article was originally published in The Gray Sheet
Executive Summary
Microtek Medical plans to maximize infection and fluid control drape sales growth by relying on a procedural-based marketing approach recently implemented by its sales force, according to President & CEO Dan Lee
You may also be interested in...
Microtek/IMP
Dip-molded medical device maker International Medical Products BV is acquired by Microtek May 28 from Cardinal Health, adding about $12 mil. in annual revenues. Microtek, which recorded 2003 revenue of $98.7 mil., notes the purchased product lines consist primarily of ultrasound probe covers and include cardiac thoracic drain systems, gynecological devices and wound care products. The move strengthens infection control offerings and expands European operations, Microtek says in a release...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.